Thermage vs. Micro-Focused Ultrasound with Visualization (MFU-V)
For facial skin tightening, MFU-V (Ultherapy) demonstrates superior efficacy and longer-lasting results compared to Thermage radiofrequency, with both modalities showing comparable safety profiles.
Direct Comparison Evidence
The only head-to-head randomized trial comparing radiofrequency (RF) to MFU-V specifically evaluated neck laxity 1. Both subsurface monopolar radiofrequency (SMRF) and MFU-V achieved significant improvements in neck laxity by day 90 that persisted to day 180, with no statistically significant differences in efficacy between the two technologies. However, MFU-V was associated with more procedural pain 1.
Efficacy Considerations
MFU-V (Ultherapy) Advantages:
- Targets multiple tissue depths precisely (1.5mm to 4.5mm) including the superficial musculoaponeurotic system (SMAS), allowing treatment of both superficial and deep structural laxity 2, 3
- Visualization capability enables real-time targeting of specific tissue planes, improving precision 3
- Sustained improvements up to 1 year documented in multiple studies, with 95% of subjects showing improvement at 12 months 4
- Dual-depth treatment protocols show superior results compared to single-depth approaches 5
- Quantitative analysis in Asians demonstrated significant submental lift (26.44mm at 90 days) and brow lift (0.47mm at 90 days) 6
Thermage (RF) Characteristics:
- Two treatments yield significantly better results than single treatment, particularly for nasolabial folds (p=0.04) 7
- Continued improvement observed between 1-month and 4-month follow-up 7
- Overall improvements described as "modest" in most patients, though 75% would consider repeat treatments 7
- Energy levels typically range 85-135 J/cm² titrated to patient tolerance 7
Duration of Results
MFU-V demonstrates more robust longevity data:
- Improvements maintained at 12 months in 95% of subjects 4
- Self-reported improvements at 1 year: 79% less sagging, 58% fewer lines/wrinkles, 47% smoother texture 4
- Peak effect at 90 days with sustained benefit to 180 days 1, 6
Thermage shows:
- Progressive improvement from 1 to 4 months post-treatment 7
- Limited long-term data beyond 4 months in available studies
- May require repeat treatments for maintenance 7
Safety Profile
Both modalities demonstrate excellent safety:
MFU-V:
- Self-limited erythema and edema 2
- More procedural pain compared to RF 1
- No unexpected adverse events across multiple studies 4, 5, 8
- Safe for periorbital treatment with appropriate transducer selection 8
Thermage:
- Mild edema and mild-to-moderate erythema as acute response 7
- No burns, skin breakdown, or scarring reported 7
- Generally well-tolerated with transient adverse events 1
Clinical Algorithm for Selection
Choose MFU-V when:
- Patient has moderate skin laxity requiring deeper tissue targeting
- Precision targeting of SMAS layer is desired
- Single treatment preferred (though dual-depth protocols optimize results)
- Longer duration of effect is priority
- Patient can tolerate higher procedural discomfort
Choose Thermage when:
- Patient has mild skin laxity
- Lower procedural pain tolerance
- Patient willing to undergo 2 treatments spaced 1 month apart for optimal results
- Budget constraints favor potentially lower per-session cost
Consider combination approaches:
- Fractional RF microneedling combined with platelet-rich plasma (PRP) shows enhanced efficacy for skin quality 9
- Synchronized RF with high-intensity facial electrical stimulation (HIFES) demonstrates significant improvements in both skin laxity and quality 10
Critical Caveats
- Peak MFU-V results occur at 90 days, with some regression by 180 days in certain anatomic areas (e.g., brow height) 6
- Consider repeat MFU-V treatment at 3 months if initial response suboptimal 6
- Thermage requires 2 treatments for optimal results—single treatment yields inferior outcomes 7
- Neither modality replaces surgical intervention for severe laxity 2
- Patient selection is critical: both work best for mild-to-moderate laxity 2, 3